Abstract:Reverse total shoulder arthroplasty (RTSA) is an established treatment for elderly patients with irreparable rotator cuff tears, complex proximal humerus fractures, and revision arthroplasty; however, with the increasing indications for RTSA over the last decade and younger implant recipients, post-operative complications have become more frequent, which has driven advances in computational modeling and simulation of reverse shoulder biomechanics. The objective of this study was to provide a review of previous… Show more
“…(1) Meticulous care should be taken when choosing the right patients for PSI because the technology is relatively novel, and long-term outcomes remain equivocal. (2) The choice of technique to overcome glenoid bone loss must consider the needs of individual patients. Each of the relevant methods has its own strengths and limitations, and any surgical decision, be it excessive reaming, the use of an alternate centerline, bone grafting, or PSI, must be patient-centered and discussed with them.…”
Section: Recommendationsmentioning
confidence: 99%
“…Total shoulder arthroplasty has become more common in recent years because of its high success with excellent outcomes [ 1 ]. Reverse total shoulder arthroplasty (RTSA) reverses the ball-and-socket shoulder joint and medializes the center of the joint to enhance the function of the deltoid muscle and increase stability in rotator cuff-deficient shoulders in a semi-constrained way [ 2 ]. Since the introduction of RTSA in 1985 by Paul Grammont and its approval by the Food and Drug Administration in 2004, it has gained a massive boost in popularity, which has contributed to an increase in the incidence of shoulder arthroplasty procedures [ 1 ].…”
Section: Introductionmentioning
confidence: 99%
“…A recent study with a large population reported that RTSA has a complication rate of 16.1% [ 5 ]. Some of the most frequent complications are scapular notching, acromial fracture, instability, component loosening (humeral and glenoid), infection, and neurologic injury [ 2 , 4 , 6 , 7 ]. Glenoid component mispositioning is a common and serious complication of RTSA that requires special consideration, even in seemingly straightforward cases [ 8 ].…”
Reverse total shoulder arthroplasty (RTSA) is widely popular among shoulder surgeons and patients, and its prevalence has increased dramatically in recent years. With this increased use, the indicated pathologies associated with RTSA are more likely to be encountered, and challenging patient presentations are more likely to be seen. One prominent challenging presentation is RTSA patients with severe glenoid bone loss. Several techniques with varying degrees of invasiveness, including excessive reaming, alternate centerline, bone grafting, and patient-specific implants (PSIs), have been developed to treat patients with this presentation. PSI treatment uses a three-dimensional reconstruction of a computed tomography scan to design a prosthetic implant or component customized to the patient’s glenoid morphology, allowing compensation for any significant bone loss. The novelty of this technology implies a paucity of available literature, and although many studies show that PSIs have good potential for solving challenging shoulder problems, some studies have reported questionable and equivocal outcomes. Additional research is needed to explore the indications, outcomes, techniques, and cost-efficiency of this technology to help establish its role in current treatment guidelines and strategies.
“…(1) Meticulous care should be taken when choosing the right patients for PSI because the technology is relatively novel, and long-term outcomes remain equivocal. (2) The choice of technique to overcome glenoid bone loss must consider the needs of individual patients. Each of the relevant methods has its own strengths and limitations, and any surgical decision, be it excessive reaming, the use of an alternate centerline, bone grafting, or PSI, must be patient-centered and discussed with them.…”
Section: Recommendationsmentioning
confidence: 99%
“…Total shoulder arthroplasty has become more common in recent years because of its high success with excellent outcomes [ 1 ]. Reverse total shoulder arthroplasty (RTSA) reverses the ball-and-socket shoulder joint and medializes the center of the joint to enhance the function of the deltoid muscle and increase stability in rotator cuff-deficient shoulders in a semi-constrained way [ 2 ]. Since the introduction of RTSA in 1985 by Paul Grammont and its approval by the Food and Drug Administration in 2004, it has gained a massive boost in popularity, which has contributed to an increase in the incidence of shoulder arthroplasty procedures [ 1 ].…”
Section: Introductionmentioning
confidence: 99%
“…A recent study with a large population reported that RTSA has a complication rate of 16.1% [ 5 ]. Some of the most frequent complications are scapular notching, acromial fracture, instability, component loosening (humeral and glenoid), infection, and neurologic injury [ 2 , 4 , 6 , 7 ]. Glenoid component mispositioning is a common and serious complication of RTSA that requires special consideration, even in seemingly straightforward cases [ 8 ].…”
Reverse total shoulder arthroplasty (RTSA) is widely popular among shoulder surgeons and patients, and its prevalence has increased dramatically in recent years. With this increased use, the indicated pathologies associated with RTSA are more likely to be encountered, and challenging patient presentations are more likely to be seen. One prominent challenging presentation is RTSA patients with severe glenoid bone loss. Several techniques with varying degrees of invasiveness, including excessive reaming, alternate centerline, bone grafting, and patient-specific implants (PSIs), have been developed to treat patients with this presentation. PSI treatment uses a three-dimensional reconstruction of a computed tomography scan to design a prosthetic implant or component customized to the patient’s glenoid morphology, allowing compensation for any significant bone loss. The novelty of this technology implies a paucity of available literature, and although many studies show that PSIs have good potential for solving challenging shoulder problems, some studies have reported questionable and equivocal outcomes. Additional research is needed to explore the indications, outcomes, techniques, and cost-efficiency of this technology to help establish its role in current treatment guidelines and strategies.
“…3 The most frequently reported complications of RSA are scapular notching, implant loosening, glenohumeral joint instability, and acromial and scapular spine stress fractures (AF/SSF). 3,4 As implant designs, techniques, and overall understanding of RSA biomechanics have improved with time, rates of many early complications, such as implant loosening and instability, have markedly decreased in recent years. Despite these advancements, the rate of AF/ SSF remains steady at 2% to 3%, 3 with some studies reporting rates as high as 7%.…”
Immobilization for acromial and scapular spine stress AU4fractures (AF/SSF) after reverse total shoulder arthroplasty (RSA) is associated with patient dissatisfaction. Our study reports the effects and safety of intranasal calcitonin alongside sling immobilization on pain and function in the treatment of AF/SSF after RSA. The treatment was regimented calcitonin (salmon) 200 unit/actuation nasal spray (1 spray/day) for 6 weeks with sling immobilization for 4 weeks. Each patient was monitored through blood work. Visual analog scale, American Shoulder and Elbow Surgeons score, and active range of motion were collected preoperatively, postoperatively, at presentation of AF/SSF, and after completion of calcitonin treatment. Two hundred eighty-two RSAs were performed by two board-certified orthopaedic surgeons, of which 18 patients sustained AF/SSF (6.4%). Ten patients met inclusion criteria (nine AFs and one SSF). After calcitonin treatment, patients demonstrated an average improvement of visual analog scale of 5.8 points, active range of motion of 46_, and American Shoulder and Elbow Surgeons score of 43.6 points at average 7.53 months after RSA. No medical complications were reported at 6-month follow-up after calcitonin treatment. The use of intranasal calcitonin was not associated withadverse events including no aberrations/signs of cancer at 6-month follow-up after administration. Calcitonin with sling immobilization markedly improved clinical and functional outcomes of patients with nondisplaced AF/SSF and may be considered by orthopaedic surgeons for symptom management.
“…The integration of patient-specific morphological and functional data into computer model-based planning devices is one of the major challenges and could still improve postoperative results. 9,10 The extraction of patient anatomical data is based on static threedimentional (3D) imaging in the supine position. 11 However, the scapula may have a different position depending on the position of the patient.…”
ObjectivesA new ultrasound‐based device is proposed to non‐invasively measure the orientation of the scapula in the standing position to consider this parameter for Total Shoulder Arthroplasty. The aim of this study was to assess the accuracy and reliability of this device.MethodsAccuracy was assessed by comparing measurements made with the ultrasound device to those acquired with a three‐dimensional (3D) optical localization system (Northern Digital, Canada) on a dedicated mechanical phantom. Three users performed 10 measurements on three healthy volunteers with different body mass (BMI) indices to analyze the reliability of the device by measuring the intra and interobserver variabilities.ResultsThe mean accuracy of the device was 0.9°± 0.7 (0.01–3.03), 1.3°± 0.8 (0.03–4.55), 1.9°± 1.5 (0.05–5.76), respectively, in the axial, coronal, and sagittal planes. The interobserver and intraobserver variabilities were excellent whatever the BMI and the users experience.ConclusionsThe device is accurate and reliable enough for the measurement of the scapula orientation in the standing position.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.